Finance

Why Pharvaris (PHVS) Is Up 7.3% And What's Next After Phase 3 Trial Success

Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock Has Average Target Price of $47.20 According to Analysts

Global markets today: GIFT Nifty, Nikkei 225, Kospi slide on Tuesday, 20 October | Nasdaq, S&P, DJIA rise up to 1%

CNBC Daily Open: Tech investors buy the dip — but debt remains a concern